The High Level Advisory Group acts as strategic counsel to the project partners and acts as a third-party validator to review the challenges and their potential solutions identified during the course of the project
Professor of Entrepreneurship, Lead for IESE/Chair of HLAG.
Professor and head of department of Entrepreneurship, holder of the Bertrán Foundation Chair of Entrepreneurship at IESE.
Primary area of interest is the entrepreneurial process, which includes the identification, evaluation and implementation of opportunities in any context. Central to this work is developing strategies and systems that help established firms achieve profitable growth.
Second work stream focuses on understanding the key factors in building and managing professional service firms. Has had the opportunity to develop both areas of interest through teaching, research projects and consulting work.
Nominated Kauffman Emerging Scholar for her dissertation work and has published in international journals and congress proceedings, both for practitioners as well as the academic community. Also authored teaching materials and contributions to several books on entrepreneurship and strategy related topics.
Holds a DBA in business administration from Harvard University, an MBA from IESE Business School, and a degree in industrial engineering from the Universitat Politécnica de Catalunya.
Businessperson who has been the head of 6 different companies and currently occupies the position of Chairman at Oneaccess, Inc., Chairman at Oneaccess Belgium BV and Chairman & Chief Executive Officer of Ekinops SA, Chairman of Ekinops Corp. and Chairman & Chief Executive Officer of OneAccess SA (both are subsidiaries of Ekinops SA). Mr. Brédy is also on the board of Oneaccess (India).
Previously held the position of General Manager of Ingenico Group SA, Principal at Xerox Corp., Head-Marketing at Pacific Data Products, Chief Executive Officer for Ivex Corp and Vice President-Marketing at Truevision, Inc.
Received a graduate degree from Télécom ParisTech and an MBA from San Jose State University.
Director, Rubato Associates
A highly-experienced institutional private equity and venture capital fund investor with considerable board and committee experience in a wide range of organizations in the UK and abroad.
Broad mix of business experience and skills beyond her core skill as an investment manager, including good strategic and risk management awareness, an alertness to the opportunities and threats of innovation and change.
Gillian is highly experienced in stakeholder relationships, identifying and dealing with conflicts of interest and has strong experience of regulation and policy-making in the alternative investment market.
She is particularly interested in the interplay between investing in growing businesses and policy-making.
President, Federation of individual investors and investment clubs
Managing partner at Reputation Age, a digital influence strategy agency, which supports clients on their issues: communication, reputation, data.
Head of Listing France, Chairman and CEO of EnterNext, Euronext
Joined Euronext Group as Chief Executive Officer of EnterNext in July 2013.
Began his career in 1986 at Société Générale, where he joined the ECM team in 1992. Joined the Oddo Corporate Finance teams in 2003 to lead the Equity Capital Markets business, in charge of IPOs, capital increases and secondary investments. Responsible for the Corporate Broking activity of Oddo Corporate Finance.
For the last fifteen years, he has been constantly mobilizing for SMEs and mid-cap companies by actively participating in reflections of Place on the subject. In his daily business at Oddo, he has accompanied many mid-market companies in their market access as President of ALIS, the Listing Sponsors of Euronext Growth. At the head of EnterNext, Eric Forest is responsible, in Europe, for all activities and resources related to SMEs and mid-cap companies within the Euronext Group.
Member of the Advisory Committee of Issuers of the Autorité des Marchés Financiers.
CEO, board member & advisor, Little Venice Partners
CEO, board member & advisor, with a focus on corporate development and M&A in the software, media and telecoms industries.
Co-author of the book ‘Getting Between the Balance Sheets, the four things every entrepreneur should know about finance.’
Specialties: Fund raising, M&A, carve-outs, take-private, roll-ups. Developing and implementing growth strategies, especially on an international scale. CEO coach and advisor.
CEO, Amadeus Partners
Chief Executive and Co-founder of Amadeus Capital Partners Limited and she brings together her many threads of experience — as a scientist, operating manager, and venture capitalist.
Lived in the US, working in manufacturing with Cummins Engine Company, and in strategy consulting with Bain & Co. in Boston, before returning to the UK to join Apax Partners & Co in 1989 to invest in early stage companies. Became Chief Operating Officer of one of her investee companies, Virtuality Group plc, after it listed on the London Stock Exchange in 1993, and then returned to investing as a business angel before founding Amadeus in 1997.
Serves on the boards of Glysure, Covestor Inc, and Nomad plc. Currently Chairman of the European Private Equity and Venture Capital Association (EVCA) and a member of the European Commission’s Research, Innovation, and Science Policy Expert (RISE) High-Level Group. Member of the UK Government’s Council for Science and Technology and of the London Business School’s Private Equity Institute Advisory Board.
Chairman of the British Private Equity & Venture Capital Association (BVCA) from 2004 to 2005, and a non-executive director of the UK Technology Strategy Board from 2005-2012.
Holds an MA in Metallurgy & Materials Science from Clare College, Cambridge, and a Masters in Public and Private Management from Yale School of Management. In 2006 awarded a CBE for services to business, and in 2008 was elected an honorary fellow of the Royal Academy of Engineering.
Seasoned Entrepreneur and Investment Banking professional. His expertise ranges from Technology, Financial Services, Social Entrepreneurship, Retail, Impact Investing and Healthcare on a global basis.
Travelled extensively, spending over 15 years in India, Asia and Africa building businesses, corporate finance and managing funds.
As an Investment Banker at Sphere Partners, Lehman Brothers, JP Morgan and BZW (Barclays) he raised over $40 billion worldwide for companies globally and advised on Private Equity; IPOs; Privatisations; Placements; Debt finance; Equity-linked products and M&A (mergers and acquisitions) strategy.
Managing Partner, Sofinnova Partners
Specializes in industrial biotechnology investments. Joined Sofinnova Partners in 1991. In charge of the technology transfer department at the Institut National de la Recherche Agronomique (INRA), France’s agricultural research institute for five years.
Joined the venture capital industry in 1989 as director of investments at Innolion (Crédit Lyonnais). During his first 17 years at Sofinnova Partners, carried out many investments in Health Care such as Nicox, Oxford Glycosciences, Oxford Molecular, PPL Therapeutics, Conjuchem, Exonhit, IDM, Innate Pharma, Ablynx, Cerenis, and Noxxon (all of which successfully went public) as well as Novexel (sold to Astrazeneca), and Crop Design (sold to BASF Crop Sciences). Recently specialized in Industrial Biotech and invested in BioAmber and Avantium (both went public respectively on NYSE and Euronext Amsterdam) and in Green Biologics and Agrosafe.
Chairman of Sofinnova Partners between 2007 and 2017, and founded in 1997 the French biotech entrepreneurs association, France Biotech. Graduate in engineering from Ecole Polytechnique and Ecole du Génie Rural des Eaux et Forêts. Degree in Innovation Management from the Université de Paris-Dauphine.
Co-Founder, Invest Securities
Responsible for the development of Small cap operations of the Crédit du Nord Group from 1994 to 1998, and then with the stockbroker Pinatton from 1998 to 2000.
Responsible for more than 100 stockmarket listings. Independent assessor approved by the AMF.
His expertise especially involves Equity Capital Market and Tech sector (biotech, medtech, IT, cleantech) operations.